AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sita-IN M Tablet

Prescription Icon
Prescription Required

Marketer

Xena Coronus Health Care Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sita-IN M Tablet

DiabetaComb M tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like nephropathy and vision loss, and may lessen the risk of cardiovascular events. DiabetaComb M may be used alone or in conjunction with other antidiabetic therapies, and is most effective when coupled with a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood glucose readings, and other medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinue only under your physician's guidance. Adherence to your prescribed diet and exercise plan is crucial for optimal diabetes control. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and sore throat. Hypoglycemia is a potential side effect, especially if used with insulin or sulfonylureas; learn to recognize and manage this complication. This medication is not universally suitable. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic issues, or excessive alcohol consumption before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Drug interactions are possible; disclose all medications to your doctor to ensure safety. Alcohol should be minimized due to its hypoglycemic effect. Your physician will monitor kidney function and blood glucose levels throughout your treatment.

Primary Ingredients of Sita-IN M Tablet

No text provided to rephrase.

Uses of Sita-IN M Tablet

Managing type 2 diabetes

Major Benefits of Sita-IN M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sita-IN M Tablet whole; do not crush, chew, or divide it. Administer this medicine with food.

Common Side effects of Sita-IN M Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sita-IN M Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sita-IN M Tablet should be administered with a meal.

How Sita-IN M Tablet works:

Sita-IN M Tablet combines sitagliptin and metformin to effectively manage blood sugar. Sitagliptin boosts insulin production from the pancreas, improves the body's insulin utilization, and lessens the liver's glucose output. Metformin, a biguanide, works by reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol and Sita-IN M Tablet should not be taken together.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sita-IN M Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers before prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sita-IN M Tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sita-IN M Tablets cautiously, potentially requiring dosage modification under medical supervision. The medication is contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

The use of Sita-IN M Tablets is contraindicated in individuals with hepatic impairment; it's advisable to seek medical counsel before taking this medication.

What if you forget to take Sita-IN M Tablet :

Should you forget a Sita-IN M Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Sita-IN M Tablet

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Treatment

FAQs on Sita-IN M Tablet

Sita-IN M Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication helps control blood sugar when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Sita-IN M Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sita-IN M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Sita-IN M Tablets are contraindicated in patients with known hypersensitivity to any ingredient or excipient. This medication should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sita-IN M Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sita-IN M Tablet) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sita-IN M and seek immediate medical attention.
Sita-IN M Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sita-IN M Tablet may cause common side effects including low blood sugar, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Avoid Sita-IN M Tablets if you're allergic to any ingredient. This medication is also contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sita-IN M Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (Sita-IN M Tablet) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sita-IN M and seek immediate medical attention.
Prolonged Sita-IN M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left untreated. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sita-IN M Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sita-IN M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sita-IN M Tablets are contraindicated in patients with known hypersensitivity to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sita-IN M Tablet and alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (Sita-IN M Tablet) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sita-IN M and seek immediate medical attention.
Prolonged Sita-IN M Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sita-IN M Tablet
193